[Treatment of irritable bowel syndrome with Escherichia coli strain Nissle 1917 (EcN): a retrospective survey].
about
Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An updateClinical use of E. coli Nissle 1917 in inflammatory bowel disease.Enhanced wound healing by recombinant Escherichia coli Nissle 1917 via human epidermal growth factor receptor in human intestinal epithelial cells: therapeutic implication using recombinant probiotics.Medical management of irritable bowel syndrome in 2008: current and future directions.The role of probiotics and prebiotics in inducing gut immunity.The probiotic Escherichia coli Nissle 1917 inhibits propagating colonic contractions in the rat isolated large intestine.
P2860
[Treatment of irritable bowel syndrome with Escherichia coli strain Nissle 1917 (EcN): a retrospective survey].
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
[Treatment of irritable bowel ...... EcN): a retrospective survey].
@ast
[Treatment of irritable bowel ...... EcN): a retrospective survey].
@en
type
label
[Treatment of irritable bowel ...... EcN): a retrospective survey].
@ast
[Treatment of irritable bowel ...... EcN): a retrospective survey].
@en
prefLabel
[Treatment of irritable bowel ...... EcN): a retrospective survey].
@ast
[Treatment of irritable bowel ...... EcN): a retrospective survey].
@en
P1433
P1476
[Treatment of irritable bowel ...... EcN): a retrospective survey].
@en
P2093
Dominik Plassmann
Hildegard Schulte-Witte
P304
P356
10.1007/S00063-007-1116-2
P407
P577
2007-11-01T00:00:00Z